Novo Nordisk's pricing tactics inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of cost gouging, declaring the stark contrast involving U.S. costs and people in Europe and copyright. At the guts in the weight-loss revolution are